Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Olaparib and Entinostat in Patients With Recurrent, Platinum-Refractory, Resistant Ovarian, Primary Peritoneal, Fallopian Tube Cancers

Vanderbilt-Ingram Cancer Center · 2020
ClinicalTrials.gov · Datasets · License: Public Domain · 2020
Open Source ↗
fallopian tube cancer, fallopian tube carcinosarcoma, fallopian tube clear cell adenocarcinoma, fallopian tube endometrioid adenocarcinoma, high grade fallopian tube serous adenocarcinoma, high grade ovarian serous adenocarcinoma, ovarian carcinosarcoma, ovarian clear cell adenocarcinoma, ovarian endometrioid adenocarcinoma, primary peritoneal serous adenocarcinoma, recurrent endometrial carcinoma, recurrent ovarian carcinoma
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 837064
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.